The Sh/R-apatinib mice showed a decreased tumor volume and a lower tumor weight than the control mice, which suggested that VEGFA inhibition impaired the EHD1-induced effect on tumor growth (Fig. 6c-e). The gene discussed is VEGFA; the disease is neoplasm.